| Price | $0.84 |
| Year Range | $0.65 – $2.47 |
| Market Cap | $6.5M |
| Industry | Biotechnology |
What Is Creative Medical Tech’s AI Stock Analysis?
Creative Medical Tech’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Creative Medical Tech’s momentum in near-real time.
Creative Medical Tech (CELZ) has an AltIndex AI Score of 42/100, currently a Hold signal. The AI Score distills Creative Medical Tech's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Creative Medical Tech’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Creative Medical Tech — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving CELZ’s AI Score?
Fundamentals
Net income for the last quarter was $-1.5M. This represents a decrease of 7.61% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 22.60%, which may be a cause for concern. Ebitda for the last quarter was $-1.5M. This represents a decrease of 7.62% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 28.00%, which may be a cause for concern.
See Creative Medical Tech’s earnings and insider transactions.
Technicals
Today's stock price is $0.84. This represents a decrease of 11.58% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 74.77%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $0.91, which is lower than the previous SMA10 of $0.93. This suggests a potential downward trend in price movement. The RSI is 82.2, indicating a potentially overbought (bearish) condition.
See the full technical analysis and price prediction.
Alternative data
Creative Medical Tech has an estimate of 1,000 visitors to their webpage, with no meaningful increase or decrese in the last couple of months.
Explore Creative Medical Tech’s job postings, web traffic and app downloads.
Sentiment & social
Add to that that the sentiment is down by -100% in the last couple of weeks, an even more concerning trend. Creative Medical Tech has 790 followers on their Twitter page. The number of followers is down by -1% in the last couple of months, indicating a loss in interest in the company.
Track Creative Medical Tech’s market sentiment.
Frequently Asked Questions: Creative Medical Tech AI Stock Analysis
Creative Medical Tech's AltIndex AI Score is 42/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Creative Medical Tech a Hold (42/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Creative Medical Tech — company overview, fundamentals, technicals and alternative data, with a recommendation. See the CELZ AI Score or sign up to read the full thesis.
